SERA PROGNOSTICS, INC. (SERA) Form 8-K — Aug 12, 2026

$SERAForm 8-KItems 2.02, 9.01Filed Aug 12, 2026, 4:08 PM ET0001193125-26-346846Original filing

Sera Prognostics furnished its second quarter 2026 results under Item 2.02, reporting revenue of $30,000 versus $17,000 in the year-ago quarter and a net loss of $9.1 million versus $8.0 million, with total operating expenses of $10.0 million. The company ended the quarter with approximately $80.3 million in cash, cash equivalents and available-for-sale securities, which management believes will fund operations through significant adoption and commercialization milestones through 2029.

Key figures

Revenue: 30000
Guidance: Management believes ~$80.3 million in cash, cash equivalents and available-for-sale securities will fund operations through significant adoption and commercialization milestones through 2029; R&D spending expected to decline in future periods.
Total Assets: 86737000
Cash Position: 80300000
Cash Runway: through 2029
Total Liabilities: 27357000
Rnd Expense Q2 2026: $3.5 million vs $3.3 million prior year
Accumulated Deficit: 329260000
Payer Opportunities: more than 20 opportunities across over 20 states
Sgna Expense Q2 2026: $6.5 million vs $6.0 million prior year
Six Month Revenue2025: 55000
Six Month Revenue2026: 44000
Prime Subgroup Results: 22% reduction in NICU admissions among first-time mothers, 30% reduction in severe composite neonatal morbidity, 28 pregnancies screened/treated to prevent one NICU admission
Net Loss Per Share Q2 2026: -$0.18 vs -$0.16 prior year
Prior Year Quarter Revenue: 17000
Total Stockholders Equity: 59380000
Operating Expenses Q2 2026: $10.0 million vs $9.3 million in Q2 2025
Weighted Avg Shares Q2 2026: 50476874
Partnership Programs Launched: 4
Illinois Annual Medicaid Births: approximately 50,000

Price after filing

1 day: -0.5%7 days: -1.5%30 days: +0.5%

Close on the filing date to close N calendar days later (from $2.02). Historical, not a forecast.

AI analysis

Red flags4 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.